We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

New Genetics and Society

Call for New Genetics and Society Special Issues

Submit Your Research

Call for New Genetics and Society Special Issues

New Genetics and Society (NGS) has a long tradition of publishing special issues on topics of particular interest to its readership. In order to formalise this process and allow better management of special issues we are issuing this call to prospective guest editors.

At NGS, we are committed to promoting and embedding equality, diversity and inclusion (EDI) in the journal. Therefore, selection of special issues will depend, in part, on the commitment of the guest editorial team towards diversity in all its forms, including working to ensure contributors to the issue are from a genuinely diverse background in a broad sense; we encourage applications from teams that have taken EDI into account. This might be represented through, but isn’t limited to, inclusion of early career researchers, colleagues from outside Europe/North America, scholars of colour, and independent scholars without current institutional affiliation. Please explain in your proposal how you have taken diversity into consideration.

If you are interested in guest editing a special issue of the journal for publication please submit a proposal including the following details:

  • Title for the special issue

  • Description of the overall topic (max 1 side)

  • If a closed call: Abstracts for each paper. Abstracts to be between 100 and 250 words each. (N.B if you prefer an open call for papers no abstracts are required)

  • Names of all guest Editors, including their affiliations and emails

  • Any specific submission instructions

  • Deadlines for submissions

  • Any relevant social media handles (for promotion)

    New Genetics and Society is from 2022 a Gold Open Access journal, meaning that publication requires payment of Article Publishing Charges (APCs). Further information is available on the journal website, including information on any available waivers. APCs may be covered via grant funding agencies or institutions.

    All submissions should be sent to [email protected] for consideration by the Editors.

    Why publish open access?

    • Increase the visibility and readership of your research by publishing in a fully open access journal.

    • Make an impact beyond the academy by making your article accessible to anyone, anywhere (including readers in industry and even policy-makers).

    • Freely share your work with no restrictions or paywall.

    • Retain ownership of your research through our unrestrictive publishing agreements.

    • Discounts and waivers for researchers in developing countries are available. The journal will also consider requests for discretionary APC waivers. Find out if your institution or country has an open access agreement to publish with us.

    Read the latest open access research published in the journal

    Authors Published Research Article
    Léo Pio-Lopez The rise of the biocyborg: synthetic biology, artificial chimerism and human enhancement
    Ayo Wahlberg, Dong Dong, Priscilla Song & Zhu Jianfeng The platforming of human embryo editing: prospecting “disease free” futures
    Brigitte Nerlich & Aleksandra Stelmach Gene drive communication: exploring experts’ lived experience of metaphor use
    Terese Knoppers, Elisabeth Beauchamp, Ken Dewar, Sarah Kimmins, Guillaume Bourque, Yann Joly & Charles Dupras The omics of our lives: practices and policies of direct-to-consumer epigenetic and microbiomic testing companies
    Rebecca Dimond, Jamie Lewis & Gareth Thomas Editorial: themed issue: understanding the technical and social landscape of gene editing
    Find the latest tweets from @tandfbiosci

    We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.